Renal outcome in adults with renal insufficiency and irregular asymmetric kidneys

BMC Nephrology

Volumn 5, Issue , 2004, Pages

  Neild, Guy H ^a,b   Thomson, Gill ^a   Nitsch, Dorothea ^c   Woolfson, Robin G ^b   Connolly, John O ^b   Woodhouse, Christopher R J ^a  

^a INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; BLADDER FUNCTION; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSPLASIA; KIDNEY FAILURE; MALE; PATIENT; PROGNOSIS; PROTEINURIA; REGRESSION ANALYSIS; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDIES; VESICO-URETERAL REFLUX;

EID: 8844233467     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-5-12     Document Type: Article

References (31)

1. British Association for Paediatric Nephrology. Report from the Paediatric Renal Registry. The UK Renal Registry 5th Annual Report 2002:253-273.
2. Arze RS, Ramos JM, Owen JP, Morley AR, Elliott RW, Wilkinson R, Ward MK, Kerr DN: The natural history of chronic pyelonephritis in the adult. Q J Med 1982, 51:396-410.
3. Goodship TH, Stoddart JT, Martinek V, Geetha D, Brown AL, Ward MK, Kerr DN, Owen JP, Wilkinson R: Long-term follow-up of patients presenting to adult nephrologists with chronic pyelonephritis and 'normal' renal function. QJM 2000, 93:799-803.
4. el Khatib MT, Becker GJ, Kincaid-Smith PS: Reflux nephropathy and primary vesicoureteric reflux in adults. Q J Med 1990, 77:1241-1253.
5. Zhang Y, Bailey RR: A long term follow up of adults with reflux nephropathy. N Z Med J 1995, 108:142-144.
6. Zucchelli P, Gaggi R: Reflux nephropathy in adults. Nephron 1991, 57:2-9.
7. Hodson CJ, Edwards D: Chronic pyelonephritis and vesicoureteric reflux. Clin Radiol 1960, 11:219-231.
8. Bailey RR: The relationship of vesico-ureteric reflux to urinary tract infection and chronic pyelonephritis-reflux nephropathy. Clin Nephrol 1973, 1:132-141.
9. Goldraich NP, Ramos OL, Goldraich IH: Urography versus DMSA scan in children with vesicoureteric reflux. Pediatr Nephrol 1989, 3:1-5.
10. Elison BS, Taylor D, Van der Wall H., Pereira JK, Cahill S, Rosenberg AR, Farnsworth RH, Murray IP: Comparison of DMSA scintigraphy with intravenous urography for the detection of renal scarring and its correlation with vesicoureteric reflux. Br J Urol 1992, 69:294-302.
11. Gordon I, Barkovics M, Pindoria S, Cole TJ, Woolf AS: Primary vesicoureteric reflux as a predictor of renal damage in children hospitalized with urinary tract infection: a systematic review and meta-analysis. J Am Soc Nephrol 2003, 14:739-744.
12. Kincaid-Smith P, Becker G: Reflux nephropathy and chronic atrophic pyelonephritis: a review. J Infect Dis 1978, 138:774-780.
13. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982, 307:652-659.
14. Chantler C, Garnett ES, Parsons V, Veall N: Glomerular filtration rate measurement in man by the single injection method using 51Cr-EDTA. Clin Sci 1969, 37:169-180.
15. Jelliffe RW: Estimation of creatinine clearance when urine cannot be collected. Lancet 1971, 1:975-976.
16. Jelliffe RW: Creatinine clearance: bedside estimate. Ann Intern Med 1973, 79:604-605.
17. Luke DR, Halstenson CE, Opsahl JA, Matzke GR: Validity of creatinine clearance estimates in the assessment of renal function. Clin Pharmacol Ther 1990, 48:503-508.
18. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993, 329:1456-1462.
19. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia): Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997, 349:1857-1863.
20. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996, 334:939-945.
21. Bailey RR, Lynn KL, Buttimore AL, Robson RA: End-stage reflux nephropathy. Proceedings of the 2nd CJ Hodson Symposium on Reflux Nephropathy Edited by: BaileyRR. Christchurch, New Zealand; 1991:49-52.
22. Bailey RR, Lynn KL, Robson RA: End-stage reflux nephropathy. Ren Fail 1994, 16:27-35.
23. Craig JC, Irwig LM, Knight JF, Roy LP: Does treatment of vesicoureteric reflux in childhood prevent end-stage renal disease attributable to reflux nephropathy? Pediatrics 2000, 105:1236-1241.
24. Nakashima Y, Matsuoka H, Oshima K, Sakamoto K: Progression of renal disease in patients with reflux nephropathy. Follow-up study. Nippon Hinyokika Gakkai Zasshi 1997, 88:557-565.
25. Matsuoka H, Oshima K, Sakamoto K, Taguchi T, Takebayashi S: Renal pathology in patients with reflux nephropathy. The turning point in irreversible renal disease. Eur Urol 1994, 26:153-159.
26. Tada M, Jimi S, Hisano S, Sasatomi Y, Oshima K, Matsuoka H, Takebayashi S: Histopathological evidence of poor prognosis in patients with vesicoureteral reflux. Pediatr Nephrol 2001, 16:482-487.
27. Smellie JM, Barratt TM, Chantler C, Gordon I, Prescod NP, Ransley PG, Woolf AS: Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet 2001, 357:1329-1333.
28. Parkhouse HF, Barratt TM, Dillon MJ, Duffy PG, Fay J, Ransley PG, Woodhouse CR, Williams DI: Long-term outcome of boys with posterior urethral valves. Br J Urol 1988, 62:59-62.
29. Reinberg Y, de Castano,I, Gonzalez R: Prognosis for patients with prenatally diagnosed posterior urethral valves. J Urol 1992, 148:125-126.
30. Burbige KA, Lebowitz RL, Colodny AH, Bauer SB, Retik AB: The megacystis-megaureter syndrome. J Urol 1984, 131:1133-1136.
31. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986, 77:1993-2000.